Global Anemia Drugs Market By Drug Type (Supplements (Iron Supplements and Vitamin Supplements) and Drugs (Erythropoiesis-Stimulating Agents (ESAs), Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs), Iron Chelators and Others)), By Indication (Iron Deficiency, Chronic Kidney Disease, Vitamin B12/Folic Acid Deficiency, Sickle Cell Anemia, Aplastic Anemia, Thalassemia and Others), By Route of Administration (Oral and Injectable), By End-User (Hospitals and Infusion Centers, Specialty Clinics and Nephrology Centers, Homecare Settings and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Dec 2025
- Report ID: 172589
- Number of Pages: 200
- Format:
-
keyboard_arrow_up
-
-
- CSL Vifor
- Amgen Inc.
- Sanofi S.A.
- AbbVie Inc.
- Daiichi Sankyo Company, Ltd.
- Pharmacosmos A/S
- AMAG Pharmaceuticals, Inc.
- Akebia Therapeutics, Inc.
- Pieris Pharmaceuticals
- Pfizer Inc.
- Takeda
- Novartis
- Johnson & Johnson
- Roche
- Biocon Biologics
- Otsuka Pharma
- Hikma Pharmaceuticals PLC
- Zydus Lifesciences Limited
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible


